Evidence map›Paper›PMID 30646487›Full record

ArticleJournal of neurogastroenterology and motility2019

Success and Complication Rates After Sacral Neuromodulation for Fecal Incontinence and Constipation: A Single-center Follow-up Study.

Bernhard Widmann, Christian Galata, Rene Warschkow, Ulrich Beutner, Önder Ögredici, Franc H Hetzer, Bruno M Schmied, Stefan Post, Lukas Marti

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of neurogastroenterology and motility, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02836717 (Long Term Efficacy of Sacral Nerve Modulation), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02836717 completednot on this map

Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence

TypeobservationalSponsorCantonal Hospital of St. GallenRan2016 to 2016Enrolled101ConditionsConstipation, Fecal IncontinenceArmssacral nerve modulation
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice.Neuromodulation : journal of the International Neuromodulation Society · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Bernhard WidmannDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Christian GalataDepartment of Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Rene WarschkowDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Ulrich BeutnerDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Önder ÖgrediciDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Franc H HetzerDepartment of Surgery, Spital Linth, Uznach, Switzerland.
Bruno M SchmiedDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Stefan PostDepartment of Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Lukas MartiDepartment of General, Visceral, Endocrine and Transplantation Surgery, Kantonsspital St. Gallen, Switzerland.
Kantonsspital St. Gallen · CHUniversity Medical Centre Mannheim · DEHeidelberg University · DESpital Linth · CHUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThe aim of this study was to evaluate the sustainability of sacral neuromodulation (SNM) success in patients with fecal incontinence (FI) and/or constipation.

methodsThis is a retrospective analysis of a prospective database of patients who received SNM therapy for FI and/or constipation between 2006 and 2015. Success rates, complications and reintervention rates were assessed after up to 10 years of follow-up.

resultsElectrodes for test stimulation were implanted in 101 patients, of whom 79 (78.2%) received permanent stimulation. The mean follow-up was 4.4 ± 3.0 years. At the end of follow-up, 57 patients (72.2%) were still receiving SNM. The 5-year success rate for FI and isolated constipation was 88.2% (95% confidence interval [CI], 80.1-97.0%) and 31.2% (95% CI, 10.2-95.5%), respectively (

conclusionsSNM offers an effective sustainable treatment for FI. For constipation, lasting success of SNM is limited and is thus not recommended. Reinterventions are necessary but do not impede treatment success.

Indexed as

ConstipationElectric stimulationFecal incontinenceSacral nerve stimulationSacral neuromodulation

Identifiers

PMID30646487
PMCPMC6326196
OpenAlexW2910049612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.